• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单克隆丙种球蛋白病中骨改变的定量组织学研究的重要性。

Importance of quantitative histology of bone changes in monoclonal gammopathy.

作者信息

Bataille R, Chappard D, Alexandre C, Dessauw P, Sany J

出版信息

Br J Cancer. 1986 Jun;53(6):805-10. doi: 10.1038/bjc.1986.136.

DOI:10.1038/bjc.1986.136
PMID:3718833
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2001420/
Abstract

Quantitative histology of bone changes, using undecalcified transiliac bone biopsies (UTBB), was performed blindly in 46 individuals with monoclonal gammopathy (MG), including 17 with MG of undetermined significance (MGUS) and 29 with overt multiple myeloma (MM). Three MGUS presented an excess of osteoclastic resorption (OR) in the vicinity of clusters of tumour cells and developed overt B cell malignancies, chronic lymphocytic leukaemia, Waldenström's disease and MM respectively. On the other hand, MGUS with normal OR remained stable (median follow-up = 28 months), with one exception who developed a systemic amyloidosis. In MM, excessive OR was only observed in areas invaded by myeloma cells. OR was frequently normal in active MM lacking myeloma cells in UTBB. Active MM without lesions on radiography had excessive OR. IgA and pure Bence Jones MM appeared more osteoclastic than IgG cases (P less than 0.05). Of major interest was the finding that one third of MM presented histological bone changes similar to osteoporosis, osteosclerosis or osteoblastic metastasis. Two major findings must be emphasized from the current data: UTBB could be of major interest for the early detection of a B cell malignancy; heterogeneity of myeloma bone condition is unexpected. If some changes appear directly related to the tumour (i.e. excessive OR or osteoblastic dysfunction), some others are probably accidentally associated with it (i.e. osteoporosis), both needing treatment other than chemotherapy.

摘要

使用未脱钙的髂骨活检(UTBB)对46例单克隆丙种球蛋白病(MG)患者进行了骨变化的定量组织学分析,其中包括17例意义未明的单克隆丙种球蛋白病(MGUS)和29例显性多发性骨髓瘤(MM)。3例MGUS在肿瘤细胞簇附近出现破骨细胞吸收(OR)增加,并分别发展为显性B细胞恶性肿瘤、慢性淋巴细胞白血病、华氏巨球蛋白血症和MM。另一方面,OR正常的MGUS保持稳定(中位随访时间 = 28个月),只有1例发展为系统性淀粉样变性。在MM中,仅在骨髓瘤细胞浸润区域观察到过度的OR。在UTBB中缺乏骨髓瘤细胞的活动性MM中,OR通常正常。X线片上无病变的活动性MM有过度的OR。IgA和纯本-周蛋白MM比IgG病例表现出更多的破骨细胞活性(P小于0.05)。最值得关注的发现是,三分之一的MM呈现出与骨质疏松、骨硬化或成骨细胞转移相似的组织学骨变化。从当前数据中必须强调两个主要发现:UTBB对于早期发现B细胞恶性肿瘤可能具有重要意义;骨髓瘤骨状况的异质性出乎意料。如果一些变化似乎与肿瘤直接相关(即过度的OR或成骨细胞功能障碍),那么其他一些变化可能与肿瘤偶然相关(即骨质疏松),两者都需要化疗以外的治疗。

相似文献

1
Importance of quantitative histology of bone changes in monoclonal gammopathy.单克隆丙种球蛋白病中骨改变的定量组织学研究的重要性。
Br J Cancer. 1986 Jun;53(6):805-10. doi: 10.1038/bjc.1986.136.
2
Quantifiable excess of bone resorption in monoclonal gammopathy is an early symptom of malignancy: a prospective study of 87 bone biopsies.单克隆丙种球蛋白病中可量化的骨吸收过多是恶性肿瘤的早期症状:87例骨活检的前瞻性研究
Blood. 1996 Jun 1;87(11):4762-9.
3
3D osteocyte lacunar morphometry of human bone biopsies with high resolution microCT: From monoclonal gammopathy to newly diagnosed multiple myeloma.人骨活检的高分辨率 microCT 三维骨细胞陷窝形态计量学:从单克隆丙种球蛋白病到新诊断的多发性骨髓瘤。
Bone. 2024 Dec;189:117236. doi: 10.1016/j.bone.2024.117236. Epub 2024 Aug 14.
4
Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.意义未明的单克隆丙种球蛋白病和冒烟型多发性骨髓瘤
Hematol Oncol Clin North Am. 2014 Oct;28(5):775-90. doi: 10.1016/j.hoc.2014.06.005. Epub 2014 Jul 22.
5
Differentiation of monoclonal gammopathy of undetermined significance and multiple myeloma using flow cytometric characteristics of plasma cells.利用浆细胞的流式细胞术特征鉴别意义未明的单克隆丙种球蛋白病和多发性骨髓瘤。
Haematologica. 2001 Aug;86(8):837-43.
6
Monoclonal gammopathy of undetermined significance: a new proposal of workup.意义未明的单克隆丙种球蛋白病:一项新的检查建议。
Eur J Haematol. 2013 Oct;91(4):356-60. doi: 10.1111/ejh.12172. Epub 2013 Aug 17.
7
[Benign monoclonal gammopathy].[良性单克隆丙种球蛋白病]
Nihon Rinsho. 1995 Mar;53(3):720-4.
8
[Monoclonal gammopathy of undetermined significance and asymptomatic multiple myelom in the year 2014 ].2014年意义未明的单克隆丙种球蛋白病及无症状多发性骨髓瘤
Vnitr Lek. 2014 Oct;60(10):861-79.
9
Prognostic Impact of Serum Heavy/Light Chain Pairs in Patients With Monoclonal Gammopathy of Undetermined Significance and Smoldering Myeloma: Long-Term Results From a Single Institution.血清重链/轻链对在意义未明的单克隆丙种球蛋白病和冒烟型骨髓瘤患者中的预后影响:来自单一机构的长期结果
Clin Lymphoma Myeloma Leuk. 2016 Jun;16(6):e71-7. doi: 10.1016/j.clml.2016.02.034. Epub 2016 Feb 27.
10
Diagnostic criteria of multiple myeloma.多发性骨髓瘤的诊断标准。
Hematol Oncol Clin North Am. 1992 Apr;6(2):347-58.

引用本文的文献

1
Mathematical modelling of the pathogenesis of multiple myeloma-induced bone disease.多发性骨髓瘤所致骨病发病机制的数学建模
Int J Numer Method Biomed Eng. 2014 Nov;30(11):1085-102. doi: 10.1002/cnm.2645. Epub 2014 May 9.
2
Targeting bone as a therapy for myeloma.将骨骼作为骨髓瘤的一种治疗靶点。
Cancer Microenviron. 2011 Dec;4(3):299-311. doi: 10.1007/s12307-011-0079-2. Epub 2011 Aug 11.
3
Dendritic cells and malignant plasma cells: an alliance in multiple myeloma tumor progression?树突状细胞与恶性浆细胞:多发性骨髓瘤肿瘤进展中的联盟?
Oncologist. 2011;16(7):1040-8. doi: 10.1634/theoncologist.2010-0327. Epub 2011 Jun 9.
4
The role of the BMP signaling antagonist noggin in the development of prostate cancer osteolytic bone metastasis.骨成型蛋白信号拮抗剂 noggin 在前列腺癌溶骨性骨转移发展中的作用。
PLoS One. 2011 Jan 13;6(1):e16078. doi: 10.1371/journal.pone.0016078.
5
Tumor-host cell interactions in the bone disease of myeloma.骨髓瘤骨病中的肿瘤-宿主细胞相互作用。
Bone. 2011 Jan;48(1):121-8. doi: 10.1016/j.bone.2010.06.029. Epub 2010 Jul 13.
6
Expression of CD56/neural cell adhesion molecule correlates with the presence of lytic bone lesions in multiple myeloma and distinguishes myeloma from monoclonal gammopathy of undetermined significance and lymphomas with plasmacytoid differentiation.CD56/神经细胞黏附分子的表达与多发性骨髓瘤中溶骨性骨病变的存在相关,并可将骨髓瘤与意义未明的单克隆丙种球蛋白病及伴有浆细胞样分化的淋巴瘤区分开来。
Am J Pathol. 2002 Apr;160(4):1293-9. doi: 10.1016/S0002-9440(10)62556-4.
7
Serum bone sialoprotein as a marker of tumour burden and neoplastic bone involvement and as a prognostic factor in multiple myeloma.血清骨唾液蛋白作为肿瘤负荷、肿瘤性骨受累的标志物以及多发性骨髓瘤的预后因素。
Br J Cancer. 2001 Feb 2;84(3):344-51. doi: 10.1054/bjoc.2000.1614.
8
Multiple myeloma: effect of daily dichloromethylene bisphosphonate on skeletal complications.多发性骨髓瘤:每日二氯亚甲基二膦酸盐对骨骼并发症的影响
Ann Hematol. 1993 Mar;66(3):141-6. doi: 10.1007/BF01697625.
9
Osteosclerotic myeloma with polyneuropathy and hypocalcemia.伴有多神经病和低钙血症的骨硬化性骨髓瘤。
Blut. 1989 Apr;58(4):207-10. doi: 10.1007/BF00320775.
10
Bone marrow biopsy in monoclonal gammopathies: correlations between pathological findings and clinical data. The Cooperative Group for Study and Treatment of Multiple Myeloma.单克隆丙种球蛋白病的骨髓活检:病理结果与临床数据的相关性。多发性骨髓瘤研究与治疗协作组。
J Clin Pathol. 1990 Jun;43(6):469-75. doi: 10.1136/jcp.43.6.469.

本文引用的文献

1
Relation of osteoclast activating factor production to extent of bone disease in multiple myeloma.破骨细胞激活因子产生与多发性骨髓瘤骨病程度的关系。
Br J Haematol. 1981 Jan;47(1):21-30. doi: 10.1111/j.1365-2141.1981.tb02758.x.
2
Smoldering multiple myeloma.冒烟型多发性骨髓瘤
N Engl J Med. 1980 Jun 12;302(24):1347-9. doi: 10.1056/NEJM198006123022405.
3
Comparison of bone scintigraphy and radiography in multiple myeloma.多发性骨髓瘤中骨闪烁显像与X线摄影的比较
Radiology. 1980 Mar;134(3):723-8. doi: 10.1148/radiology.134.3.7355226.
4
Quantitative histology of myeloma-induced bone changes.骨髓瘤所致骨改变的定量组织学
Br J Haematol. 1982 Dec;52(4):601-10. doi: 10.1111/j.1365-2141.1982.tb03936.x.
5
Clinical evaluation of myeloma osteoclastic bone lesions: II. Induced hypocalcemia test using salmon calcitonin.骨髓瘤破骨性骨病变的临床评估:II. 使用鲑鱼降钙素的低钙血症诱发试验。
Metab Bone Dis Relat Res. 1982;4(1):39-42. doi: 10.1016/0221-8747(82)90007-8.
6
In vitro osteolytic activity of human myeloma plasma cells and the clinical evaluation of myeloma osteoclastic bone lesions.人骨髓瘤浆细胞的体外溶骨活性及骨髓瘤破骨细胞性骨病变的临床评估
Br J Cancer. 1984 Jul;50(1):119-21. doi: 10.1038/bjc.1984.147.
7
The Crow-Fukase syndrome: a study of 102 cases in Japan.克劳-深泽综合征:日本102例病例研究
Neurology. 1984 Jun;34(6):712-20. doi: 10.1212/wnl.34.6.712.
8
Low plasma cell 3(H) thymidine incorporation in monoclonal gammopathy of undetermined significance (MGUS), smouldering myeloma and remission phase myeloma: a reliable indicator of patients not requiring therapy.意义未明的单克隆丙种球蛋白病(MGUS)、冒烟型骨髓瘤和缓解期骨髓瘤中低浆细胞3(H)胸苷掺入:无需治疗患者的可靠指标
Br J Haematol. 1984 Dec;58(4):689-96. doi: 10.1111/j.1365-2141.1984.tb06116.x.
9
Comparison of two long-term chemotherapy regimens, with or without agents to modify skeletal repair, in multiple myeloma.两种长期化疗方案在多发性骨髓瘤中的比较,这两种方案使用或不使用改善骨骼修复的药物。
Blood. 1984 Mar;63(3):639-48.
10
Clinical, morphological, and cell kinetic differences among multiple myeloma, monoclonal gammopathy of undetermined significance, and smoldering multiple myeloma.多发性骨髓瘤、意义未明的单克隆丙种球蛋白病和冒烟型多发性骨髓瘤之间的临床、形态学及细胞动力学差异
Blood. 1983 Jul;62(1):166-71.